David E. Cohn

22.0k total citations · 2 hit papers
377 papers, 12.2k citations indexed

About

David E. Cohn is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, David E. Cohn has authored 377 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Reproductive Medicine, 149 papers in Obstetrics and Gynecology and 95 papers in Oncology. Recurrent topics in David E. Cohn's work include Endometrial and Cervical Cancer Treatments (143 papers), Ovarian cancer diagnosis and treatment (138 papers) and Uterine Myomas and Treatments (54 papers). David E. Cohn is often cited by papers focused on Endometrial and Cervical Cancer Treatments (143 papers), Ovarian cancer diagnosis and treatment (138 papers) and Uterine Myomas and Treatments (54 papers). David E. Cohn collaborates with scholars based in United States, Japan and Australia. David E. Cohn's co-authors include Jeffrey M. Fowler, Kimberly Resnick, David M. O’Malley, Floor Backes, Larry J. Copeland, David G. Mutch, Adrian A. Suarez, Debra L. Richardson, Leigh G. Seamon and Karuppaiyah Selvendiran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

David E. Cohn

357 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

2008 539 citations David E. Cohn et al. Gynecologic Oncology profile →
Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

2009 497 citations D. Scott McMeekin, David E. Cohn et al. profile →

Peers

Countries citing papers authored by David E. Cohn

Since Specialization

Citations

This map shows the geographic impact of David E. Cohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Cohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Cohn more than expected).

Fields of papers citing papers by David E. Cohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Cohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Cohn. The network helps show where David E. Cohn may publish in the future.

Co-authorship network of co-authors of David E. Cohn

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Cohn. A scholar is included among the top collaborators of David E. Cohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Cohn. David E. Cohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer 2023 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Floor Backes, David E. Cohn, Paul J. Goodfellow, Casey Cosgrove	10
2	Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubbles 2023 ·Gynecologic Oncology ·(unknown), Kalpana Deepa Priya Dorayappan, (unknown), Adrian A. Suarez, (unknown), (unknown), G. Larry Maxwell, David M. O’Malley, David E. Cohn, Michael F. Tweedle, Karuppaiyah Selvendiran	0
3	Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis 2021 ·Journal of Gynecologic Oncology ·(unknown), David E. Cohn, J. Michael Straughn, Sarah Dilley	24
4	Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity 2020 ·Clinical Cancer Research ·Bangxing Hong, (unknown), Uksha Saini, (unknown), David E. Cohn, Guangan He, Zahid H. Siddik, Anil K. Sood, Yuanqing Yan, Karuppaiyah Selvendiran, Guangsheng Pei, Zhongming Zhao, Ji Young Yoo, Balveen Kaur	23
5	Inhibition of miR-328–3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer 2019 ·Cancer Research ·Amit Kumar Srivastava, Ananya Banerjee, Tiantian Cui, Chunhua Han, Shurui Cai, Lu Liu, Dayong Wu, Ri Cui, Zaibo Li, Xiaoli Zhang, (unknown), Karuppaiyah Selvendiran, Srinivas Patnaik, Adam R. Karpf, Jinsong Liu, David E. Cohn, Qi-En Wang	74
6	A Microfluidic Chip Enables Isolation of Exosomes and Establishment of Their Protein Profiles and Associated Signaling Pathways in Ovarian Cancer 2019 ·Cancer Research ·Kalpana Deepa Priya Dorayappan, Miranda L. Gardner, Colin L. Hisey, Roman A. Zingarelli, (unknown), (unknown), Rajan Gogna, (unknown), John L. Hays, Derek J. Hansford, Michael A. Freitas, Lianbo Yu, David E. Cohn, Karuppaiyah Selvendiran	88
7	STAT3/PIAS3 Levels Serve as “Early Signature” Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube 2018 ·Cancer Research ·Uksha Saini, Adrian A. Suarez, Shan K. Naidu, John Wallbillich, Kristin Bixel, Ross Wanner, (unknown), Raleigh D. Kladney, Jenny Lester, Beth Y. Karlan, Paul J. Goodfellow, David E. Cohn, Karuppaiyah Selvendiran	17
8	Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP) 2018 ·Gynecologic Oncology ·Emily Ko, Laura J. Havrilesky, Ronald D. Alvarez, Oliver Zivanovic, Leslie R. Boyd, Elizabeth L. Jewell, Patrick Timmins, (unknown), Anuja Jhingran, David E. Cohn, Sean C. Dowdy, Matthew A. Powell, Eva Chalas, Yongmei Huang, (unknown), Jason D. Wright	9
9	Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center 2018 ·Gynecologic Oncology ·Adam C. ElNaggar, Erinn M. Hade, David M. O’Malley, Margaret Liang, Larry J. Copeland, Jeffrey M. Fowler, Ritu Salani, Floor Backes, David E. Cohn	12
10	Factors Associated With Deciding Between Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening Among High-Risk Women Enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group Study 2017 ·Obstetrical & Gynecological Survey ·(unknown), Marion Piedmonte, Paul K. J. Han, Richard P. Moser, Joan L. Walker, Gustavo C. Rodriguez, John F. Boggess, Thomas Rutherford, Oliver Zivanovic, David E. Cohn, J.T. Thigpen, Robert M. Wenham, Michael Friedländer, Chad A. Hamilton, Jamie N. Bakkum‐Gamez, Alexander Olawaiye, Martee L. Hensley, Mark H. Greene, Helen Huang, Lari Wenzel	1
11	A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer 2016 ·Journal of Minimally Invasive Gynecology ·David E. Cohn, (unknown), Laura Huffman, Ritu Salani, Jeffrey M. Fowler, Larry J. Copeland, David M. O’Malley, Floor Backes, Eric Eisenhauer, Mahmoud Abdel‐Rasoul, Erika Puente-Poushnejad, Sergio D. Bergese	18
12	Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer 2016 ·Obstetrical & Gynecological Survey ·Katharine M. Esselen, Angel M. Cronin, Kristin Bixel, Michael A. Bookman, Robert A. Burger, David E. Cohn, Mihaela Cristea, Jennifer J. Griggs, Charles F. Levenback, Gina Mantia-Smaldone, Larissa A. Meyer, Ursula A. Matulonis, Joyce C. Niland, Charlotte C. Sun, David M. O’Malley, Alexi A. Wright	13
13	Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer 2015 ·Obstetrical & Gynecological Survey ·Alexi A. Wright, Angel M. Cronin, Dana Milne, Michael A. Bookman, Robert A. Burger, David E. Cohn, Mihaela Cristea, Jennifer J. Griggs, Nancy L. Keating, Charles F. Levenback, Gina Mantia-Smaldone, Ursula A. Matulonis, Larissa A. Meyer, Joyce C. Niland, Jane C. Weeks, David M. O’Malley	5
14	Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial 2015 ·Obstetrical & Gynecological Survey ·Ashley S. Felix, Louise A. Brinton, D. Scott McMeekin, William T. Creasman, David G. Mutch, David E. Cohn, Joan L. Walker, Richard G. Moore, Levi S. Downs, Robert A. Soslow, Richard J. Zaino, Mark E. Sherman	2
15	HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer 2014 ·Cancer Research ·Kellie S. Rath, Shan K. Naidu, (unknown), Hemant K. Bid, Brian K. Rivera, Georgia A. McCann, Brent J. Tierney, Adam C. ElNaggar, (unknown), Gustavo Leone, Peter J. Houghton, Kálmán Hideg, Periannan Kuppusamy, David E. Cohn, Karuppaiyah Selvendiran	76
16	Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates 2007 ·Cancer Research ·David Gius, (unknown), Eric Y. Chuang, Sheng Feng, Phyllis C. Huettner, Loan Nguyen, C. Matthew Bradbury, Mark V. Mishra, Shuping Gao, Barbara M. Buttin, David E. Cohn, Matthew A. Powell, Neil S. Horowitz, Bradford P. Whitcomb, Janet S. Rader	76
17	La naranja mecánica 2006 ·David E. Cohn	3
18	Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum 2000 ·Gut ·Jeremy R. Jass, Hiroshi Iino, Andrew Ruszkiewicz, Dorothy M. Painter, Michael J. Solomon, David J. Koorey, David E. Cohn, Kevin Furlong, Michael D. Walsh, Juan Palazzo, Tina Bocker Edmonston, Richard Fishel, Joanne Young, Barbara Leggett	194
19	Prevention of Rhinovirus Infection in Chimpanzees by Soluble Intercellular Adhesion Molecule-1 1997 ·American Journal of Respiratory and Critical Care Medicine ·E D Huguenel, David E. Cohn, (unknown), J M Greve, Michael A. Fournel, (unknown), Regina Irwin, (unknown), Alan McClelland, Elizabeth Muchmore, A Ohlin, Philip Scuderi	53
20	Maximal Inspiratory Pressures and Dimensions of the Diaphragm 1997 ·American Journal of Respiratory and Critical Care Medicine ·F. Dennis McCool, (unknown), Joshua O. Benditt, David E. Cohn, Charles B. Sherman, F. G. Hoppin	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact